LakeShore Biopharma Co., Ltd Cash Flow Quality Index

Latest as of June 2022: -0.06x

LakeShore Biopharma Co., Ltd cash flow quality index. LakeShore Biopharma Co., Ltd (LSBCF) has a Cash Flow Quality Index of -0.06x as of June 2022. Operating cash flow of $-693.96K is below net income of $11.52 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is LakeShore Biopharma Co., Ltd to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.06x
Operating CF / Net Income

Operating Cash Flow

$-693.96K
USD

Net Income

$11.52 Million
USD

Data as of

Jun 2022
Most recent filing

LakeShore Biopharma Co., Ltd Cash Flow Quality Index by Year (None–None)

LakeShore Biopharma Co., Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for LakeShore Biopharma Co., Ltd. For the full cash flow conversion analysis, see LakeShore Biopharma Co., Ltd operating cash flow efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.